{"id":447207,"title":"Health Canada New Drug Authorizations: 2016 Highlights - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:52:40.269000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-canada-new-drug-authorizations-2016-highlights.html?wbdisable=false","snippet":"Health Canada New Drug Authorizations: 2016 Highlights Table of Contents Foreword New Active Substances Overview New Active Substances Issued Marketing Authorization with Conditions New Active Substances Authorized with a Priority Review New Active Substance Authorized for…","rawSnapshotUrl":"/api/snapshots/raw/447207","browseUrl":"https://replay.healtharchive.ca/job-6/20260103135240/https://www.canada.ca/en/health-canada/services/publications/drugs-health-products/health-canada-new-drug-authorizations-2016-highlights.html?wbdisable=false#ha_snapshot=447207","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}